ILM1.DE
ILM1.DE
DE000A1MMCC8
Medios AG I
Loading chart...

Company Profile

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG was founded in 2015 and is headquartered in Berlin, Germany.

Related stocks

UPR.IR
UPR.IR • Ireland
UNIPHAR PLC
3.84 EUR
1.12B USD 1Y +2.5%
ARJO-B.ST
ARJO-B.ST • Sweden
Arjo AB ser. B
27.18 SEK
740.74M USD 1Y -13.2%
ASKER.ST
ASKER.ST • Sweden
Asker Healthcare Group AB
68.85 SEK
2.64B USD 1Y -20%
AMP.MI
AMP.MI • Italy
AMPLIFON
12.86 EUR
3.83B USD 1Y -20.6%
7476.T
7476.T • Japan
AS ONE CORPORATION
2,495 JPY
1.12B USD 1Y -1.2%
GALE.SW
GALE.SW • Switzerland
GALENICA N
85.2 CHF
5.11B USD 1Y -4.1%
603368.SS
603368.SS • China
GUANGXI LIUYAO GROUP CO LTD
15.48 CNY
920.07M USD 1Y -18%
9987.T
9987.T • Japan
SUZUKEN CO LTD
2,600 JPY
2.19B USD 1Y -12.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
40.0% p.a.
Max Drawdown (5Y)
-75.3%
Sharpe Ratio (5Y)
-0.62
Beta Factor
1.26
Size Class
Micro Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (40.0% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -75.6% in the extended horizon.
ende